Login / Signup

Avelumab plus axitinib for translocation renal cell carcinoma: A case series and literature review.

Kenta TakahashiRenpei KatoDaiki IkarashiTomohiko MatsuuraShigekatsu MaekawaMitsugu KanehiraRyo TakataJun SugimuraTakaya AbeWataru Obara
Published in: IJU case reports (2023)
The outcomes of these cases indicate that avelumab-axitinib therapy has a long-term antitumor effect in some patients with tRCC.
Keyphrases
  • renal cell carcinoma
  • metastatic renal cell carcinoma
  • case report
  • type diabetes
  • mesenchymal stem cells
  • glycemic control
  • weight loss
  • smoking cessation